ACTIVE SUBSTANCE CARRIER COMPRISING BIOPOLYMER

    公开(公告)号:US20210161830A1

    公开(公告)日:2021-06-03

    申请号:US17109931

    申请日:2020-12-02

    Abstract: The present disclosure relates to an active substance carrier comprising a core-shell network structure formed using a biopolymer. In an aspect of the present disclosure, the core-shell network structure comprises a core-shell particle comprising: a core comprising prolamin; and a shell comprising pullulan and pectin, wherein the pullulan comprised in the shell surrounds the core and the pectin is located in the outermost layer of the shell, so that a network is formed between the core-shell particles. It can effectively facilitate the transdermal absorption of an active substance.

    EMULSION COMPOSITION COMPRISING JELLY COAT GEL PARTICLE

    公开(公告)号:US20230348698A1

    公开(公告)日:2023-11-02

    申请号:US18306070

    申请日:2023-04-24

    Abstract: The specification relates to an emulsion composition of a formulation that can stably comprise an active substance through a biomimetic structure and can effectively deliver the active substance into the skin. The disclosure uses biocompatible natural vegetable proteins and macromolecules to mimic plant seeds with components and form a morphologically simulated structure of stem cells, so that various efficacious substances can be stably comprised in a high content in the formulation, and high skin absorbability of active substances can be provided. Accordingly, the disclosure can not only solve the safety issues caused by the use of conventional synthetic chemicals, but also enhance the effect of a cosmetic composition or pharmaceutical composition comprising an active substance by stabilizing the active substance in a formulation and effectively absorbing the active substance into the skin.

    COMPOSITION FOR INHIBITING LIPOFUSCIN ACCUMULATION OR REMOVING LIPOFUSCIN

    公开(公告)号:US20220339210A1

    公开(公告)日:2022-10-27

    申请号:US17726970

    申请日:2022-04-22

    Abstract: A composition for inhibiting lipofuscin accumulation or removing lipofuscin is disclosed. A Chryseobacterium sp. strain, a lysate of the Chryseobacterium sp. strain, a culture of the Chryseobacterium sp. strain, or an extract of the lysate or culture is included in the composition. The composition provides an anti-aging effect by inhibiting lipofuscin accumulation or removing lipofuscin. The composition also provides an effect of preventing, ameliorating or treating the diseases caused by the lipofuscin accumulation, such as skin hyperpigmentation, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, myocardial infarction and age-related macular degeneration.

Patent Agency Ranking